CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT04690192 · COMPLETED
Trial details
- NCT number
- NCT04690192
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2023-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.